Bayer Ag Ord (OP: BAYZF )

30.94 +0.16 (+0.51%)

Streaming Delayed Price Updated: 1:32 PM EDT, Aug 29, 2024 Add to My Watchlist

Price and Volume

Volume	400
Open	30.91
Bid (Size)	N/A (0)
Ask (Size)	N/A (0)
Prev. Close	30.78
Today's Range	30.91 - 30.94
52wk Range	26.91 - 57.58
Shares Outstanding	N/A
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Futures Rally Fizzles As Dollar, Yields And Oil Slump

August 17, 2024

US equity futures erased earlier gains and were trading with modest losses as the dollar, oil, and yields all slumped entering the US session.

Via Talk Markets

Bayer Weedkiller Lawsuit Dismissed By Australian Judge: Insufficient Evidence Linking Roundup To Blood Cancer

July 25, 2024

Australian judge dismisses class action lawsuit against Bayer for Roundup causing cancer. Ruling supports company's stance that product is safe.

Via Benzinga

Performance

YTD	-18.07%	-18.07%
1 Month	+4.38%	+4.38%
3 Month	+3.11%	+3.11%
6 Month	+1.74%	+1.74%
1 Year	-43.27%	-43.27%

More News

Judge Slashes Bayer's Massive $2B Roundup Verdict To $400M

June 05, 2024

Via Benzinga

After UnitedHealth Cyberattack, Drug Distributor Cencora Notifies Americans' Health Information Stolen In Data Breach In February

May 24, 2024

Via Benzinga

Bayer Highlights Detailed Data From Twin Late-Stage Trials On Experimental Menopause Candidate, Seeks Regulatory Approval

May 17, 2024

Via Benzinga

Bayer's Monsanto Scores Legal Victory as $185M Verdict Overturned

May 02, 2024

Via Benzinga

Bayer's Third Menopausal Relief Drug Trial Meets Primary Goal, German Conglomerate Seeks FDA Approval For Elinzanetant

March 19, 2024

Via Benzinga

German Conglomerate Bayer Goes Johnson & Johnson Way To Tackle Its Cancer Related Lawsuits

March 14, 2024

Via Benzinga

Bayer Holds Splitting Into Separate Units For Three Years, Focus Shifts On Tackling Challenges

March 05, 2024

Via Benzinga

What's Going On With BridgeBio Pharma Stock On Monday?

March 04, 2024

Via Benzinga

Weedkiller Woes: Australian Court Nears Decision in Bayer's Roundup Trial

January 30, 2024

Via Benzinga

Roundup Cancer Verdict: Woes Continue For Bayer As It Faces $2.2B Payout

January 29, 2024

Via Benzinga

Large Drugmakers Show Enthusiasm To Embrace $100B Obesity Market, Despite Novo And Lilly's Dominance

January 11, 2024

Via Benzinga

Menopause Management: Bayer's Non-Hormonal Treatment Option Shows Efficacy In Trial

January 08, 2024

Via Benzinga

Bayer Study On Parkinson's Disease Gene Therapy Succeeds In Early-Stage Trial

January 04, 2024

Via Benzinga

Legal Victory For Bayer: Roundup Lawsuit Ends Five-Trial Losing Streak

December 26, 2023

Via Benzinga

ESG Stocks Take Center Stage As Damages From Climate-Related Events Rise Exponentially Within US

December 19, 2023

Via Benzinga

Bayer Faces $3.5M Verdict in Fifth Consecutive Roundup Weedkiller Loss

December 06, 2023

Via Benzinga

Bayer Faces Growing Pressure Amid Roundup Lawsuits as Philadelphia Trial Nears Conclusion

December 04, 2023

Via Benzinga

German Conglomerate Bayer Faces Investor Scrutiny Amid Unexpected Legal, Trial Setbacks

November 24, 2023

Via Benzinga

Analyst Assess Implications of Bristol Myers' Investigational Blood Thinner Post Bayer Trial Setback Amid Shaken Investor Confidence

November 20, 2023

Via Benzinga

Bayer's Blood Thinner Study Stopped Early Due To Lack Of Efficacy: Details

November 20, 2023

Via Benzinga

Bayer's Legal Victory Against Merck: Delaware Court Rules In Company's Favor Regarding Talc Lawsuits

November 17, 2023

Via Benzinga

Bayer CEO Resists Full Tri-Split, German Conglomerate Cuts Management Jobs In The Face Of Q3 Loss

November 08, 2023

Via Benzinga

Legal Woes Mount for Bayer As Roundup Weed Killer-Related Cancer Cases Continue, Faces Third Trial Loss

November 01, 2023

Via Benzinga

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.